Sangamo Therapeutics, Inc. (SGMO)

Sangamo Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	82	96	515	1,093	2,207	970
Market Cap Growth	-59.56%	-81.28%	-52.90%	-50.50%	127.45%	-17.20%
Enterprise Value	58	47	274	759	1,603	648
PE Ratio	-	-0.37	-2.68	-6.13	-18.24	-10.19
PS Ratio	4.39	0.55	4.62	9.87	18.68	9.47
PB Ratio	1.45	1.16	1.75	2.91	4.43	2.24
P/FCF Ratio	-0.55	-0.39	-2.11	-4.26	14.23	-5.88
P/OCF Ratio	-0.58	-0.43	-2.30	-4.68	12.99	-6.72
EV/Sales Ratio	3.09	0.27	2.47	6.85	13.56	6.32
EV/EBITDA Ratio	-0.30	-0.20	-1.60	-4.73	-14.94	-7.57
EV/EBIT Ratio	-0.29	-0.18	-1.43	-4.26	-13.28	-6.80
EV/FCF Ratio	-0.44	-0.19	-1.13	-2.96	10.33	-3.92
Debt / Equity Ratio	0.54	0.40	0.13	0.12	0.08	0.10
Debt / EBITDA Ratio	-0.10	-0.14	-0.23	-0.27	-0.36	-0.48
Debt / FCF Ratio	-0.14	-0.14	-0.16	-0.17	0.25	-0.25
Quick Ratio	1.39	1.75	2.53	3.00	4.52	5.74
Current Ratio	1.71	1.98	2.69	3.12	4.60	5.80
Asset Turnover	0.09	0.61	0.18	0.14	0.14	0.16
Return on Equity (ROE)	-258.20%	-131.00%	-61.20%	-42.00%	-25.10%	-23.40%
Return on Assets (ROA)	-156.40%	-89.60%	-31.70%	-22.20%	-14.30%	-15.30%
Return on Capital (ROIC)	-392.58%	-235.40%	-60.27%	-43.71%	-24.14%	-22.20%
Earnings Yield	-398.11%	-267.59%	-37.37%	-16.32%	-5.48%	-9.81%
FCF Yield	-264.75%	-255.31%	-47.38%	-23.48%	7.03%	-17.01%
Buyback Yield / Dilution	-6.60%	-13.02%	-6.76%	-7.53%	-19.92%	-15.65%
Total Shareholder Return	-6.60%	-13.02%	-6.76%	-7.53%	-19.92%	-15.65%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).